--- type: "firecrawl-provider" description: "Medicines issued by NHS hospital trusts in England (England only: acute, teaching, specialist, mental health and community trusts), from the NHS Business Services Authority's Secondary Care Medicines Data (SCMD) on the NHSBSA Open Data Portal: monthly quantities of every dm+d Virtual Medicinal Product (VMP) issued by each trust from April 2019, with an indicative cost (list or reimbursement price, not the confidential price trusts paid). Finds a medicine by part of its product name or its VMP SNOMED code over up to 24 months, finalised months where NHSBSA has published them and provisional ones after, and totals it by product, by trust (with the trust's name from NHS England's ODS directory) or by month. Hospital issues only, not community prescribing. Open Government Licence v3.0; every answer carries NHSBSA's attribution and the cost caveat." use_when: "Medicines issued by NHS hospital trusts in England (England only: acute, teaching, specialist, mental health and community trusts), from the NHS Business Services Authority's Secondary Care Medicines Data (SCMD) on the NHSBSA Open Data Portal: monthly quantities of every dm+d Virtual Medicinal Product (VMP) issued by each trust from April 2019, with an indicative cost (list or reimbursement price, not the confidential price trusts paid). Finds a medicine by part of its product name or its VMP SNOMED code over up to 24 months, finalised months where NHSBSA has published them and provisional ones after, and totals it by product, by trust (with the trust's name from NHS England's ODS directory) or by month. Hospital issues only, not community prescribing. Open Government Licence v3.0; every answer carries NHSBSA's attribution and the cost caveat." categories: "Life sciences" capabilities: 1 credits_per_call: 5 --- # NHSBSA Secondary Care Medicines Data (SCMD) on Firecrawl Alexandria Medicines issued by NHS hospital trusts in England (England only: acute, teaching, specialist, mental health and community trusts), from the NHS Business Services Authority's Secondary Care Medicines Data (SCMD) on the NHSBSA Open Data Portal: monthly quantities of every dm+d Virtual Medicinal Product (VMP) issued by each trust from April 2019, with an indicative cost (list or reimbursement price, not the confidential price trusts paid). Finds a medicine by part of its product name or its VMP SNOMED code over up to 24 months, finalised months where NHSBSA has published them and provisional ones after, and totals it by product, by trust (with the trust's name from NHS England's ODS directory) or by month. Hospital issues only, not community prescribing. Open Government Licence v3.0; every answer carries NHSBSA's attribution and the cost caveat. - Categories: Life sciences - Category index: [Life sciences category](https://firecrawl.dev/alexandria/agents/categories/life-sciences) - Provider key: `opendata-nhsbsa-net` - Access: Firecrawl credits - Cost: 5 credits per call ## More - [Human guide](https://firecrawl.dev/app/alexandria/opendata-nhsbsa-net) - [OpenAPI spec](https://firecrawl.dev/alexandria/agents/providers/opendata-nhsbsa-net/openapi.json) ## 1. Choose this provider when Medicines issued by NHS hospital trusts in England (England only: acute, teaching, specialist, mental health and community trusts), from the NHS Business Services Authority's Secondary Care Medicines Data (SCMD) on the NHSBSA Open Data Portal: monthly quantities of every dm+d Virtual Medicinal Product (VMP) issued by each trust from April 2019, with an indicative cost (list or reimbursement price, not the confidential price trusts paid). Finds a medicine by part of its product name or its VMP SNOMED code over up to 24 months, finalised months where NHSBSA has published them and provisional ones after, and totals it by product, by trust (with the trust's name from NHS England's ODS directory) or by month. Hospital issues only, not community prescribing. Open Government Licence v3.0; every answer carries NHSBSA's attribution and the cost caveat. ## 2. Minimal request Call `POST https://api.firecrawl.dev/v2/scrape` with `{ alexandria: { provider, capability, options } }`. For a batch, send `{ alexandria: [...] }` with up to 10 calls. ```json { "provider": "opendata-nhsbsa-net", "capability": "hospital-medicines/search", "options": { "from": "2025-01", "medicine": "pembrolizumab", "to": "2025-12" } } ``` ## 3. Add provider options Use only the options needed for the task: - `from` (string): First month, `YYYY-MM`. SCMD starts at 2019-04. Without `from` and `to`, the latest 12 published months; with one of them, 12 months from or to it. Pattern: ^[0-9]{4}-(0[1-9]|1[0-2])$. Example: `YYYY-MM` - `group_by` (string): `product` (default): one row per VMP and unit for the whole window. `trust`: per trust and VMP, with the trust's name. `month`: per month and VMP, a time series. Example: `product` - `limit` (number): Most rows to return; `total_count` counts all and `totals` covers all. Example: `50` - `medicine` (string, required): Part of the dm+d product (VMP) name, matched case-insensitively anywhere in it: `pembrolizumab`, `adalimumab 40mg`, `insulin aspart`. Generic names, not brands (Keytruda is `pembrolizumab`). Or a VMP SNOMED code of 6 to 20 digits for one exact product: `34378411000001105`. Letters, digits, spaces and . , / % + ( ) - only. Pattern: ^[A-Za-z0-9 .,/%+()-]+$. Example: `` - `to` (string): Last month, `YYYY-MM`. At most 24 months per call; months not yet published are listed in `months_unavailable`, not refused. Pattern: ^[0-9]{4}-(0[1-9]|1[0-2])$. Example: `YYYY-MM` - `trust` (string[]): Only these trusts, by ODS code: `["RBV", "RGT"]`. Omit for every trust in England. Example: `["RBV","RGT"]` ## 4. Request through your preferred interface ### JavaScript ```javascript const result = await firecrawl.scrape({ alexandria: { provider: "opendata-nhsbsa-net", capability: "hospital-medicines/search", options: { from: "2025-01", medicine: "pembrolizumab", to: "2025-12", }, }, }); ``` ### Python ```python result = firecrawl.scrape_alexandria({ "provider": "opendata-nhsbsa-net", "capability": "hospital-medicines/search", "options": { "from": "2025-01", "medicine": "pembrolizumab", "to": "2025-12" } }) ``` ### cURL ```sh curl https://api.firecrawl.dev/v2/scrape \ -H "Authorization: Bearer $FIRECRAWL_API_KEY" \ -H "Content-Type: application/json" \ -d '{ "alexandria": { "provider": "opendata-nhsbsa-net", "capability": "hospital-medicines/search", "options": { "from": "2025-01", "medicine": "pembrolizumab", "to": "2025-12" } } }' ``` ### CLI ```sh firecrawl scrape 'opendata-nhsbsa-net/hospital-medicines/search' \ --options '{"from":"2025-01","medicine":"pembrolizumab","to":"2025-12"}' ``` ### MCP Call the FCX MCP retrieve tool with this object: ```json { "provider": "opendata-nhsbsa-net", "capability": "hospital-medicines/search", "options": { "from": "2025-01", "medicine": "pembrolizumab", "to": "2025-12" } } ``` Ask for only the returned fields needed by the task. ## 5. Full request shape ```json { "provider": "opendata-nhsbsa-net", "capability": "hospital-medicines/search", "options": { "from": "2025-01", "medicine": "pembrolizumab", "to": "2025-12" } } ``` ## 6. Response data The response includes `success`, `provider`, `capability`, `creditsCost` and `data`. This example shows the provider payload in `data`: ```json { "cost_caveat": "Indicative cost is a list or reimbursement price, not what trusts paid. NHSBSA: \"Actual costs cannot be displayed in the dataset as NHS Hospital pricing contracts and NICE Patient Access Schemes are confidential.\" It uses community pharmacy reimbursement prices for generic medicines and list prices for branded medicines, and \"does not reflect the net actual cost of NHS Trusts, which will differ due to the application of confidential discounts, rebates, or procurement agreements paid by hospitals when purchasing medicines.\" A null cost means NHSBSA holds no price for the product, not zero.", "from": "2025-01", "group_by": "product", "license": { "attribution": "Source: NHS Business Services Authority (NHSBSA), Secondary Care Medicines Data (SCMD) with indicative price, published on behalf of NHS England. Contains public sector information licensed under the Open Government Licence v3.0.", "name": "Open Government Licence v3.0", "trust_names_attribution": null, "url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/" }, "medicine": { "match": "product_name_contains", "query": "pembrolizumab" }, "months": [ { "dataset": "finalised", "month": "2025-01", "resource": "SCMD_FINAL_202501", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/5cde935b-17b6-4c6e-a2a5-bb40d0270288" }, { "dataset": "finalised", "month": "2025-02", "resource": "SCMD_FINAL_202502", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/b416af4e-fbb4-4bdf-92dc-a784947393ec" }, { "dataset": "finalised", "month": "2025-03", "resource": "SCMD_FINAL_202503", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/480e886c-0546-4f97-8e24-d134235b29ef" }, { "dataset": "finalised", "month": "2025-04", "resource": "SCMD_FINAL_202504", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/a10a727b-acfe-41bd-9a29-21f63c1f592b" }, { "dataset": "finalised", "month": "2025-05", "resource": "SCMD_FINAL_202505", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/3fe15b41-19dd-49f4-9a80-e268a9f5a40c" }, { "dataset": "finalised", "month": "2025-06", "resource": "SCMD_FINAL_202506", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/820d8017-4d2c-4df3-b185-7d78f7e07471" }, { "dataset": "finalised", "month": "2025-07", "resource": "SCMD_FINAL_202507", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/8ab7b0a8-9eaa-424c-a575-cd576e4beecd" }, { "dataset": "finalised", "month": "2025-08", "resource": "SCMD_FINAL_202508", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/bcb0933f-88d1-429e-9ee4-3a26b29b06cd" }, { "dataset": "finalised", "month": "2025-09", "resource": "SCMD_FINAL_202509", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/7c7718b2-5e8a-4224-b102-bb649a7d4a32" }, { "dataset": "finalised", "month": "2025-10", "resource": "SCMD_FINAL_202510", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/0d39f680-5bc3-4ff0-8fe8-684734d1a990" }, { "dataset": "finalised", "month": "2025-11", "resource": "SCMD_FINAL_202511", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/fd047985-d084-4d01-81df-08a75fc9a8bd" }, { "dataset": "finalised", "month": "2025-12", "resource": "SCMD_FINAL_202512", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/a767f48b-b7c4-4609-ab74-6230ddc68f82" } ], "months_unavailable": [], "results": [ { "indicative_cost_gbp": 546677520.25, "product_name": "Pembrolizumab 100mg/4ml solution for infusion vials", "quantity": 831448.7, "trusts": 104, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 0, "vmp_snomed_code": "34378411000001105" }, { "indicative_cost_gbp": 3337338.5, "product_name": "Pembrolizumab 50mg powder for solution for infusion vials", "quantity": 2537.9, "trusts": 2, "unit": "VIAL", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 0, "vmp_snomed_code": "30033011000001108" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 200mg/100ml in Sodium chloride 0.9% infusion bags", "quantity": 3383100, "trusts": 57, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 571, "vmp_snomed_code": "44064111000001104" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 400mg/100ml in Sodium chloride 0.9% infusion bags", "quantity": 1672699.5, "trusts": 50, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 466, "vmp_snomed_code": "44065011000001101" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 100mg/50ml in Sodium chloride 0.9% infusion bags", "quantity": 300, "trusts": 1, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 5, "vmp_snomed_code": "44061311000001100" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 150mg/100ml in Sodium chloride 0.9% infusion bags", "quantity": 100, "trusts": 1, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 1, "vmp_snomed_code": "44062511000001103" } ], "source_updated_at": "2026-08-25", "source_url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price", "to": "2025-12", "total_count": 6, "totals": { "indicative_cost_gbp": 550014858.75, "products": 6, "rows": 2141, "trusts": 107, "unpriced_rows": 1043 }, "warnings": [ { "code": "unpriced_rows", "message": "1043 of 2141 matched rows have no indicative cost because NHSBSA holds no price for the product; their cost is null, never 0, and indicative_cost_gbp sums only priced rows." } ] } ``` ## API reference-derived contract The following capability contract is generated from the same normalized Alexandria API reference exposed in the API spec. ### Search - Capability: `hospital-medicines/search` - Description: Quantities and indicative cost of a medicine issued by NHS hospital trusts in England, from NHSBSA's Secondary Care Medicines Data: matches part of the dm+d VMP product name (`pembrolizumab`) or one VMP SNOMED code over a window of up to 24 months (default the latest 12 published), optionally for chosen trusts, and groups by product, by trust (with ODS trust names) or by month. Each row is one VMP in one unit with its quantity, unit-dose quantity (vials, bags) where SCMD reports it, indicative cost and trust count; totals give cost, trusts, products and source rows. Each month comes from its finalised table where published, else its provisional one, and is listed with its table; unpublished months are listed, not refused. No match is an empty result. - Instructions: England hospital (secondary care) medicine use: "how much pembrolizumab NHS trusts used last year" (from 2025-01 to 2025-12), "which trusts issue the most adalimumab" (group_by trust), "monthly hospital usage of a drug" (group_by month), for epidemiology denominators in patient-based drug forecasting. Hospital issues only, not community prescribing or what the NHS paid (indicative cost is list price). For US Medicare and Medicaid drug spending use data-cms-gov drug-spending/search; for US Medicaid drug utilisation (SDUD) use data-medicaid-gov, and for US pharmacy acquisition costs data-medicaid-gov prices/search (NADAC); for Medicare negotiated prices use cms-gov negotiated-prices/search; for EU authorisation status use ema-europa-eu medicines (no usage data). - Cost: 5 credits per call - Capability file: [Search](https://firecrawl.dev/alexandria/agents/providers/opendata-nhsbsa-net/hospital-medicines/search) Accepted options: - `from` (string): First month, `YYYY-MM`. SCMD starts at 2019-04. Without `from` and `to`, the latest 12 published months; with one of them, 12 months from or to it. Pattern: ^[0-9]{4}-(0[1-9]|1[0-2])$. Example: `YYYY-MM` - `group_by` (string): `product` (default): one row per VMP and unit for the whole window. `trust`: per trust and VMP, with the trust's name. `month`: per month and VMP, a time series. Example: `product` - `limit` (number): Most rows to return; `total_count` counts all and `totals` covers all. Example: `50` - `medicine` (string, required): Part of the dm+d product (VMP) name, matched case-insensitively anywhere in it: `pembrolizumab`, `adalimumab 40mg`, `insulin aspart`. Generic names, not brands (Keytruda is `pembrolizumab`). Or a VMP SNOMED code of 6 to 20 digits for one exact product: `34378411000001105`. Letters, digits, spaces and . , / % + ( ) - only. Pattern: ^[A-Za-z0-9 .,/%+()-]+$. Example: `` - `to` (string): Last month, `YYYY-MM`. At most 24 months per call; months not yet published are listed in `months_unavailable`, not refused. Pattern: ^[0-9]{4}-(0[1-9]|1[0-2])$. Example: `YYYY-MM` - `trust` (string[]): Only these trusts, by ODS code: `["RBV", "RGT"]`. Omit for every trust in England. Example: `["RBV","RGT"]` Response schema example: ```json { "cost_caveat": "Indicative cost is a list or reimbursement price, not what trusts paid. NHSBSA: \"Actual costs cannot be displayed in the dataset as NHS Hospital pricing contracts and NICE Patient Access Schemes are confidential.\" It uses community pharmacy reimbursement prices for generic medicines and list prices for branded medicines, and \"does not reflect the net actual cost of NHS Trusts, which will differ due to the application of confidential discounts, rebates, or procurement agreements paid by hospitals when purchasing medicines.\" A null cost means NHSBSA holds no price for the product, not zero.", "from": "2025-01", "group_by": "product", "license": { "attribution": "Source: NHS Business Services Authority (NHSBSA), Secondary Care Medicines Data (SCMD) with indicative price, published on behalf of NHS England. Contains public sector information licensed under the Open Government Licence v3.0.", "name": "Open Government Licence v3.0", "trust_names_attribution": null, "url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/" }, "medicine": { "match": "product_name_contains", "query": "pembrolizumab" }, "months": [ { "dataset": "finalised", "month": "2025-01", "resource": "SCMD_FINAL_202501", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/5cde935b-17b6-4c6e-a2a5-bb40d0270288" }, { "dataset": "finalised", "month": "2025-02", "resource": "SCMD_FINAL_202502", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/b416af4e-fbb4-4bdf-92dc-a784947393ec" }, { "dataset": "finalised", "month": "2025-03", "resource": "SCMD_FINAL_202503", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/480e886c-0546-4f97-8e24-d134235b29ef" }, { "dataset": "finalised", "month": "2025-04", "resource": "SCMD_FINAL_202504", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/a10a727b-acfe-41bd-9a29-21f63c1f592b" }, { "dataset": "finalised", "month": "2025-05", "resource": "SCMD_FINAL_202505", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/3fe15b41-19dd-49f4-9a80-e268a9f5a40c" }, { "dataset": "finalised", "month": "2025-06", "resource": "SCMD_FINAL_202506", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/820d8017-4d2c-4df3-b185-7d78f7e07471" }, { "dataset": "finalised", "month": "2025-07", "resource": "SCMD_FINAL_202507", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/8ab7b0a8-9eaa-424c-a575-cd576e4beecd" }, { "dataset": "finalised", "month": "2025-08", "resource": "SCMD_FINAL_202508", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/bcb0933f-88d1-429e-9ee4-3a26b29b06cd" }, { "dataset": "finalised", "month": "2025-09", "resource": "SCMD_FINAL_202509", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/7c7718b2-5e8a-4224-b102-bb649a7d4a32" }, { "dataset": "finalised", "month": "2025-10", "resource": "SCMD_FINAL_202510", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/0d39f680-5bc3-4ff0-8fe8-684734d1a990" }, { "dataset": "finalised", "month": "2025-11", "resource": "SCMD_FINAL_202511", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/fd047985-d084-4d01-81df-08a75fc9a8bd" }, { "dataset": "finalised", "month": "2025-12", "resource": "SCMD_FINAL_202512", "unit_dose_reported": false, "url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price/resource/a767f48b-b7c4-4609-ab74-6230ddc68f82" } ], "months_unavailable": [], "results": [ { "indicative_cost_gbp": 546677520.25, "product_name": "Pembrolizumab 100mg/4ml solution for infusion vials", "quantity": 831448.7, "trusts": 104, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 0, "vmp_snomed_code": "34378411000001105" }, { "indicative_cost_gbp": 3337338.5, "product_name": "Pembrolizumab 50mg powder for solution for infusion vials", "quantity": 2537.9, "trusts": 2, "unit": "VIAL", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 0, "vmp_snomed_code": "30033011000001108" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 200mg/100ml in Sodium chloride 0.9% infusion bags", "quantity": 3383100, "trusts": 57, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 571, "vmp_snomed_code": "44064111000001104" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 400mg/100ml in Sodium chloride 0.9% infusion bags", "quantity": 1672699.5, "trusts": 50, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 466, "vmp_snomed_code": "44065011000001101" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 100mg/50ml in Sodium chloride 0.9% infusion bags", "quantity": 300, "trusts": 1, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 5, "vmp_snomed_code": "44061311000001100" }, { "indicative_cost_gbp": null, "product_name": "Pembrolizumab 150mg/100ml in Sodium chloride 0.9% infusion bags", "quantity": 100, "trusts": 1, "unit": "ML", "unit_dose_quantity": null, "unit_dose_unit": null, "unpriced_rows": 1, "vmp_snomed_code": "44062511000001103" } ], "source_updated_at": "2026-08-25", "source_url": "https://opendata.nhsbsa.net/dataset/finalised-secondary-care-medicines-data-scmd-with-indicative-price", "to": "2025-12", "total_count": 6, "totals": { "indicative_cost_gbp": 550014858.75, "products": 6, "rows": 2141, "trusts": 107, "unpriced_rows": 1043 }, "warnings": [ { "code": "unpriced_rows", "message": "1043 of 2141 matched rows have no indicative cost because NHSBSA holds no price for the product; their cost is null, never 0, and indicative_cost_gbp sums only priced rows." } ] } ```